Search for: "Wyeth Holdings LLC" Results 81 - 100 of 112
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Jun 2008, 6:31 pm
Dow Agrosciences LLC, 544 U.S. 431 (2005):In undertaking a pre-emption analysis. . ., a court should bear in mind the concept of equivalence. [read post]
9 Nov 2015, 7:09 am
Back in 2009 – when the blog was still a Bexis/Herrmann operation – we wrote a catch-all punitive damages post entitled (oddly enough) “On Punitive Damages. [read post]
25 Oct 2008, 12:18 am
You can separately subscribe to the IP Think Tank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: CAFC again affirms invalidation of claims to 'means'-defined elements involving a computer algorithm as indefinite: Net MoneyIN v Verisign (IP Updates) (IP Law Observer) (Patent Prospector) (PLI) (Patently-O) (Hal Wegner) (Law360) District Court: Patent term adjustments just got longer: Wyeth v Dudas (Patent Docs)… [read post]
2 Dec 2015, 12:38 pm by Schachtman
The Lipitor court’s holding built on the ruling by Judge Breyer’s treatment of dose in In re Bextra & Celebrex Mktg. [read post]
17 Oct 2013, 5:00 am by Bexis
  Therefore, we hold today that a plaintiff who does not read an allegedly inadequate warning cannot maintain a negligent-failure-to-adequately-warn action unless the nature of the alleged inadequacy is such that it prevents him from reading it.Id. at 971.This ruling has been extended to situations where the prescriber fails to read a warning. [read post]
15 Nov 2013, 11:34 am by Bexis
Anodyne Therapy, LLC, 589 F.3d 881, 884 (7th Cir. 2009).Once FDA-approved, prescription drugs can be prescribed by doctors for both FDA-approved and -unapproved uses; the FDA generally does not regulate how physicians use approved drugs . . . . [read post]
23 Aug 2008, 1:23 am
: (Part 1 - SPICY IP), (Part 2 - SPICY IP)   Global – Copyright International Federation of the Phonographic Industry (IFPI): ‘Three strikes’ effort hit worldwide home run: (Ars Technica), How to attribute a Creative Commons licensed work: (Molly Kleinman), Chrysalis disappoints, as new artists fail to incubate: (IP finance), DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt)     Events 26 August:… [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey shows most Americans… [read post]
25 Apr 2015, 11:03 am by Schachtman
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
1 Oct 2009, 2:14 am
May 13, 2008), hold that "properly joined and served" under 28 U.S.C. [read post]
23 Oct 2008, 9:03 am
Mass. 1986) (same).Cert. petition at 4-5, see also id. at 14-16 (more discussion of cases holding that §337(a) precludes various forms of private enforcement). [read post]
25 Jun 2014, 2:00 pm by Maureen Johnston
Wyeth, LLC; and the plain language of the federal Food, Drug, and Cosmetic Act (“FDCA”)—that federal law does not preempt state tort claims predicated on allegations that a generic drug manufacturer violated the FDCA by failing to immediately implement or otherwise disseminate notice of labeling changes that the United States Food and Drug Administration had approved for use on a generic drug product's brand-name equivalent. [read post]
31 Dec 2015, 5:12 am
The iconic Hunger Games line, “may the odds be ever in your favor” pretty much sums up how we feel about our top ten best decisions of 2015. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is objecting… [read post]
13 Jan 2011, 2:55 pm by Bexis
Dow Agrosciences LLC, 544 U.S. 431 (2005), a non-FDCA case involving violation claims under a different statute. [read post]
13 Oct 2008, 12:12 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]